
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $77M | -- | -- | $0.38 | -- |
07/21/2025 | Q2 | $74.4M | -- | -- | $0.36 | -- |
05/19/2025 | Q1 | $71.4M | $74.3M | $0.14 | $0.29 | -$0.15 |
01/21/2025 | Q4 | $73.1M | $69.6M | $0.14 | $0.34 | -$0.20 |
10/28/2024 | Q3 | $67.5M | $68.3M | $0.05 | $0.30 | -$0.25 |
07/22/2024 | Q2 | $64.4M | $63.5M | $0.50 | $0.26 | $0.25 |
05/13/2024 | Q1 | $61.9M | $62.2M | $0.11 | $0.28 | -$0.17 |
01/22/2024 | Q4 | $60.1M | $60.6M | $2.85 | $0.26 | $2.60 |
10/23/2023 | Q3 | -- | -- | $0.16 | $0.19 | -$0.03 |
07/24/2023 | Q2 | -- | -- | $0.04 | $0.14 | -$0.10 |
05/16/2023 | Q1 | -- | -- | $0.14 | $0.22 | -$0.08 |
01/24/2023 | Q4 | -- | -- | $0.13 | $0.21 | -$0.08 |
10/25/2022 | Q3 | -- | -- | $0.12 | $0.18 | -$0.06 |
07/26/2022 | Q2 | -- | -- | $0.10 | $0.18 | -$0.08 |
05/17/2022 | Q1 | -- | -- | $0.06 | $0.17 | -$0.11 |
01/25/2022 | Q4 | -- | -- | $0.04 | $0.15 | -$0.11 |
10/26/2021 | Q3 | -- | -- | $0.02 | $0.18 | -$0.16 |
07/27/2021 | Q2 | -- | -- | $0.06 | $0.17 | -$0.11 |
05/18/2021 | Q1 | -- | -- | -$1.05 | $0.19 | -$1.24 |
01/26/2021 | Q4 | -- | -- | -$0.11 | $0.21 | -$0.32 |
10/27/2020 | Q3 | -- | -- | $0.22 | $0.12 | $0.11 |
07/28/2020 | Q2 | -- | -- | -$0.07 | -$0.03 | -$0.04 |
05/21/2020 | Q1 | -- | -- | -$1.16 | -- | -- |
01/28/2020 | Q4 | -- | -- | -$0.11 | -$0.07 | -$0.05 |
10/24/2019 | Q3 | -- | -- | -$0.13 | -$0.05 | -$0.09 |
07/25/2019 | Q2 | -- | -- | -- | -$0.09 | -- |
05/16/2019 | Q1 | -- | -- | -- | -$0.09 | -- |
01/24/2019 | Q4 | -- | -- | -- | -$0.10 | -- |
10/25/2018 | Q3 | -- | -- | -- | -$0.14 | -- |
08/01/2018 | Q2 | -- | -- | -- | -- | -- |
05/24/2018 | Q1 | -- | -- | -- | -- | -- |
01/25/2018 | Q4 | -- | -- | -- | -- | -- |
11/01/2017 | Q3 | -- | -- | -- | -- | -- |
08/03/2017 | Q2 | -- | -- | -- | -- | -- |
06/01/2017 | Q1 | -- | -- | -- | -- | -- |
02/09/2017 | Q4 | -- | -- | -- | -- | -- |
11/09/2016 | Q3 | -- | -- | -- | -- | -- |
08/03/2016 | Q2 | -- | -- | -- | -- | -- |
06/09/2016 | Q1 | -- | -- | -- | -- | -- |
02/03/2016 | Q4 | -- | -- | -- | -- | -- |
11/04/2015 | Q3 | -- | -- | -- | -- | -- |
Agilysys reported $74.3M worth of top line sales in its most recent quarter.
Agilysys announced earnings per share of $0.14 which represents a miss of analyst forecast a $0.29 per share.
Agilysys reported $45.1M that represents $1.59 per share over the last quarter.
Agilysys's earnings are forecast to grow from $0.82 per share to $1.30 per share next year representing an increase of 99.19%.
Agilysys's next earnings date is July 21, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.